SastiMedic
Cytogem 200 mg Injection

Cytogem 200 mg Injection

MRP: ₹1,450.00

Packaging

1 INJECTION

Composition

Gemcitabine 200mg

Company

Dr. Reddy

Buy Now

Substitutes for Cytogem 200 mg Injection

Medicine Company Price You Save
Gemtaz 200mg Injection Sun Pharma ₹1,171.00 Save ₹279.00
Gemtrust 200mg Inj. Panacea Biotec ₹1,290.00 Save ₹160.00
Celgem-200mg Inj. Alkem Labs ₹1,332.00 Save ₹118.00
Abingem-200mg Inj. Miracauls ₹1,340.00 Save ₹110.00
Gemspera 200mg Inj. Indoco Remedies ₹1,350.00 Save ₹100.00
Oncogem 200 mg Injection Cipla ₹1,455.73
Biogem 200mg Inj. United Biotech ₹1,495.00
Gemcite-200mg Inj. Eli Lilly ₹1,855.00
Citabol 200mg Injection Venus Remedies ₹1,868.75

Side Effects of Cytogem 200 mg Injection

Bone marrow suppression as manifested by leukopenia, thrombocytopenia, anaemia and myelosuppression. Mild GI effects; rashes; renal impairment, pulmonary toxicity, influenza-like symptoms; interstitial pneumonia, pulmonary oedema. Proteinuria, haematuria and haemolytic uraemic syndrome. Elevation of serum transaminase. Potentially Fatal: Oesophagitis and pneumonitis when given with radical radiotherapy to the thorax.

Drug Interactions

May increase the anticoagulant effect of warfarin when used together.

Contraindications

Concurrent radical radiotherapy; pregnancy, lactation; hypersensitivity.

Mechanism of Action

Gemcitabine is a synthetic pyrimidine nucleoside and cytarabine analogue which is metabolised intracellularly to active diphosphate and triphosphate nucleosides. It inhibits DNA synthesis by inhibiting DNA polymerase and ribonucleotide reductase. It also induces apoptosis and is primarily active against cells in the S-phase, but may also arrest cells at the G1-S border. Metabolism: Rapidly cleared from the blood and metabolised by cytidine deaminase in the liver, kidney, blood, and other tissues after IV admin. Excretion: Mainly excreted in the urine. Half life ranges from 42-94 minutes.

Special Precautions

Children, hepatic and renal impairment. May impair ability to drive or operate machinery. Discontinue on 1st sign of microangiopathic haemolytic anaemia. Prolonged infusion time (>60 minutes) and more frequent than wkly dosing may increase toxicity. Monitor CBC before every dose. Increased risk of haemolytic uraemic syndrome and/or thrombocytcpenic purpura which may lead to irreversible renal failure.

How to Use

Take orally with food and water, as directed by your physician.

How to Store

Keep in a cool, dry place away from sunlight and moisture.

Safety Concerns

  • Alcohol: Avoid during treatment.
  • Breastfeeding: Not recommended.
  • Pregnancy: Contraindicated.
  • Liver/Kidney: Use with caution.

Content Disclaimer

This content is for educational purposes only. Please consult your doctor before use.

More brands by Dr. Reddy

Written by: SastiMedic Medical Team

Reviewed by: Registered Pharmacist